The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...
The innovation, he says, could transform the way scientists measure and address genomic breaks in gene-editing systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback